Elilly在加拿大承受得起的压力下降低了糖尿病和减重药物的价格。 Eli Lilly lowered prices on diabetes and weight-loss drugs in Canada amid affordability pressure.

根据《环球邮报》,Elilily在加拿大降低了糖尿病和减重药物的价格。 Eli Lilly has reduced the price of its diabetes and weight-loss medications in Canada, according to the Globe and Mail. 虽然报告中没有详细说明具体的价格变化和受影响的药物,但这一行动是在不断施加压力,要求提高药物的可负担性,改善药物的获取机会的情况下采取的。 The move comes amid ongoing pressure to improve drug affordability and access, though specific price changes and affected drugs were not detailed in the report. 价格调整标志着公司在加拿大市场战略的转变。 The pricing adjustment marks a shift in strategy for the company in the Canadian market.